381 related articles for article (PubMed ID: 30543572)
1. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
[TBL] [Abstract][Full Text] [Related]
2. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
[TBL] [Abstract][Full Text] [Related]
3. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
[TBL] [Abstract][Full Text] [Related]
5. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Diktas H; Karacaer Z; Özturk II; Cicek H
Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
[TBL] [Abstract][Full Text] [Related]
7. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.
Li MR; Zheng HW; Lu JH; Ma SM; Ye LH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH; Sun DX
Oncotarget; 2017 Feb; 8(7):11063-11070. PubMed ID: 28052021
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
[TBL] [Abstract][Full Text] [Related]
10. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
11. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
13. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
[TBL] [Abstract][Full Text] [Related]
14. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
15. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
[TBL] [Abstract][Full Text] [Related]
16. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
[TBL] [Abstract][Full Text] [Related]
17. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.
Li J; Mao RC; Li XL; Zheng JW; Qi X; Yuan Q; Zhang J; Zhang JM; Xia NS
Dig Liver Dis; 2018 May; 50(5):482-489. PubMed ID: 29396134
[TBL] [Abstract][Full Text] [Related]
18. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
[TBL] [Abstract][Full Text] [Related]
19. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
[TBL] [Abstract][Full Text] [Related]
20. A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.
Li L; Ye Y; Ran Y; Liu S; Tang Q; Liu Y; Liao X; Zhang J; Xiao G; Lu J; Zhang G; He Q; Hu S
Medicine (Baltimore); 2021 Apr; 100(17):e25581. PubMed ID: 33907107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]